Mutual effect of homocysteine and uric acid on arterial stiffness and cardiovascular risk in the context of predictive, preventive, and personalized medicine
Brachial-ankle pulse wave velocity
Biomedical and clinical sciences
Research
610
Health sciences
Diseases
FOS: Health sciences
Cardiovascular risk
Arterial stiffness
Predictive preventive and personalized medicine (PPPM / 3PM)
3. Good health
Mutual effect
03 medical and health sciences
0302 clinical medicine
Medicine and Health Sciences
Health services and systems
Homocysteine
Uric acid
DOI:
10.1007/s13167-022-00298-x
Publication Date:
2022-09-26T06:02:32Z
AUTHORS (12)
ABSTRACT
Arterial stiffness is a major risk factor and effective predictor of cardiovascular diseases common pathway pathological vascular impairments. Homocysteine (Hcy) uric acid (UA) own the shared metabolic pathways to affect function. Serum has great impact on arterial risk, while mutual effect with Hcy remains unknown yet. This study aimed evaluate serum UA 10-year in general population. From perspective predictive, preventive, personalized medicine (PPPM/3PM), we assumed that combined assessment provides better tool for targeted prevention intervention via suppressing stiffness.This consisted 17,697 participants from Beijing Health Management Cohort, who underwent health examination between January 2012 December 2019. Brachial-ankle pulse wave velocity (baPWV) was used as an index stiffness.Individuals both high had highest baPWV, compared those low (β: 30.76, 95% CI: 18.36-43.16 males; β: 53.53, 38.46-68.60 females). In addition, these individuals owned (OR: 1.49, 1.26-1.76 OR: 7.61, 4.63-12.68 Of note, males homocysteine were significantly associated increased 1.30, 1.15-1.47), but not group 1.02, 0.90-1.16).This found using large population suggested clinical importance evaluation control promoting health. The adverse arteriosclerosis should be addressed beyond acid, especially males. Monitoring level window opportunity PPPM/3PM progression CVD. novel identify at primary early treatment progressive stage stiffness, active levels aspects dietary behavior medication conducive alleviating reducing Further studies are needed health.The online version contains supplementary material available 10.1007/s13167-022-00298-x.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (76)
CITATIONS (14)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....